Enovis (NYSE:ENOV) PT Raised to $75.00

Enovis (NYSE:ENOV – Free Report) had its price objective boosted by Canaccord Genuity Group from $73.00 to $75.00 in a research note issued to investors on Friday morning, Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. ENOV has been the topic of a number of other research reports. Needham & […]

Related Keywords

Ohio ,United States ,William Blair ,Needham Company ,Canaccord Genuity Group ,Group Plc ,Enovis Corporation ,Virtu Financial ,Pricet Rowe Associates Inc ,Barclays Plc ,Free Report ,Genuity Group ,Trading Down ,Get Free Report ,Employees Retirement System ,General Group Plc ,Enovis Daily ,Genovis ,Nyse Enov ,Senov ,Medical ,Boost Price Target ,Canaccord Genuity Group Inc ,